KHEXF(KHEXF)
KHEXF
No analyst ratings available
No analyst price targets available for KHEXF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $388.95B | $371.15B | $391.76B | $382.43B | $401.89B |
| Low | $345.62B | $343.92B | $355.39B | $346.93B | $364.58B |
| High | $404.20B | $408.81B | $419.03B | $409.05B | $429.86B |
| EBITDA Avg | $230.57B | $220.01B | $232.23B | $226.70B | $238.24B |
| Low | $204.88B | $203.87B | $210.67B | $205.66B | $216.12B |
| High | $239.60B | $242.34B | $248.40B | $242.48B | $254.82B |
| EBIT Avg | $207.71B | $198.21B | $209.21B | $204.23B | $214.62B |
| Low | $184.58B | $183.66B | $189.79B | $185.27B | $194.70B |
| High | $215.86B | $218.32B | $223.78B | $218.45B | $229.56B |
| Net Income Avg | $31.52B | $29.39B | $28.13B | $28.58B | $30.64B |
| Low | $27.72B | $25.85B | $24.74B | $25.13B | $26.94B |
| High | $34.38B | $32.05B | $30.68B | $31.17B | $33.41B |
| EPS Avg | $116.84 | $108.94 | $104.27 | $105.93 | $113.55 |
| Low | $102.74 | $95.80 | $91.68 | $93.15 | $99.85 |
| High | $127.41 | $118.80 | $113.70 | $115.51 | $123.83 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $78.01B | $101.00B | $144.52B |
| Low | $78.01B | $101.00B | $144.52B |
| High | $78.01B | $101.00B | $144.52B |
| EBITDA Avg | $46.24B | $59.87B | $85.67B |
| Low | $46.24B | $59.87B | $85.67B |
| High | $46.24B | $59.87B | $85.67B |
| EBIT Avg | $41.66B | $53.94B | $77.18B |
| Low | $41.66B | $53.94B | $77.18B |
| High | $41.66B | $53.94B | $77.18B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |